© 2022 MJH Life Sciences and CGTLive™. All rights reserved.
© 2022 MJH Life Sciences™ and CGTLive™. All rights reserved.
Illinois Retina Associates and Assistant Professor, Ophthalmology, Rush University
October 27, 2021
John Pollack, MD, discusses gene therapy advancements for retinal diseases.
July 31, 2021
NT-501 previously received orphan drug and fast track status from the FDA and Neurotech will pursue approval in late 2022.